REILLY FINANCIAL ADVISORS, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$7,000
-22.2%
22,0110.0%0.00%0.0%
Q4 2019$9,000
+28.6%
22,0110.0%0.00%0.0%
Q3 2019$7,000
+16.7%
22,0110.0%0.00%0.0%
Q2 2019$6,000
-75.0%
22,0110.0%0.00%
-66.7%
Q1 2019$24,000
-36.8%
22,0110.0%0.00%
-50.0%
Q4 2018$38,000
-70.3%
22,0110.0%0.01%
-64.7%
Q3 2018$128,000
+36.2%
22,0110.0%0.02%
+30.8%
Q2 2018$94,000
-27.1%
22,0110.0%0.01%
-27.8%
Q1 2018$129,000
+26.5%
22,0110.0%0.02%
+28.6%
Q4 2017$102,000
-15.7%
22,0110.0%0.01%
-22.2%
Q3 2017$121,000
-4.7%
22,0110.0%0.02%
-5.3%
Q2 2017$127,0000.0%22,0110.0%0.02%
-5.0%
Q1 2017$127,000
+9.5%
22,0110.0%0.02%0.0%
Q4 2016$116,000
+81.2%
22,011
-31.2%
0.02%
+81.8%
Q3 2016$64,000
-3.0%
32,0110.0%0.01%
-8.3%
Q2 2016$66,000
-4.3%
32,0110.0%0.01%0.0%
Q1 2016$69,000
-25.0%
32,0110.0%0.01%
-25.0%
Q4 2015$92,000
-35.2%
32,0110.0%0.02%
-38.5%
Q3 2015$142,000
-13.9%
32,0110.0%0.03%
-7.1%
Q2 2015$165,00032,0110.03%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$6,545,0003.19%
COURAGE CAPITAL MANAGEMENT LLC 200,000$1,098,0000.74%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 174,512$958,0000.06%
Family Management Corp 14,000$77,0000.05%
EAM Investors, LLC 62,752$345,0000.05%
FNY Managed Accounts LLC 4,400$24,0000.03%
ACADIAN ASSET MANAGEMENT LLC 1,090,397$5,988,0000.03%
REILLY FINANCIAL ADVISORS, LLC 22,011$121,0000.02%
Alambic Investment Management, L.P. 28,500$156,0000.02%
Caprock Group, LLC 14,085$77,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders